Press Release BioNxt Advances Cladribine Clinical Program with Completion of the Investigational Medicinal Product Dossier (IMPD) Ahead of Human Clinical Studies 3 hours ago
Press Release BioNxt Provides Development, Intellectual Property and Commercial Update Across Sublingual Drug Delivery Pipeline Aug 17